Hyperuricemia

Jul 10, 2019

Gout Therapeutic Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

May 16, 2019

Data Analysis Published in Hypertension Shows Responders to Pegloticase Treatment Had Significant Decreases in Blood Pressure

Oct 02, 2018

Acquist Therapeutics to Present Scientific Results for Lead Clinical Drug in Gout

Aug 22, 2018

Study Finds Salivary Uric Acid May Be an Important Biomarker for Indexing Health & Disease Risk

Jan 17, 2018

New Nationwide Survey on Gout Finds Patients with Gout and Chronic Kidney Disease are Sub-Optimally Treated

Nov 29, 2017

Nippon Chemiphar Announces Progress on Its Hyperuricemia/Gout Projects; NC-2500 Shows Favorable Profile to Lower Serum Uric Acid in Phase-1 Study

Nov 01, 2017

TWi Biotechnology Inc. Presents Positive Results from AC-201 CR Phase 2 Proof-of-Concept Study in Gout Patients in 2017 ACR/ARPH Annual Meeting

Oct 11, 2017

Relburn-Metabolomics to Present Developments in Lead Programs for NASH and Gout

Jun 20, 2017

Kibow Biotech Inc. (Buzz of Bio Winner, 2014) Receives US Patent for Gout/Hyperuricemia Product Formulation Based on Modulation of the Gut Microbiome With Probiotics and Prebiotics